On the other hand, Grundström et al. [24] demonstrated no significant impact of anti-TNFα treatment on Treg peripheral blood level in 34 IBD patients treated with infliximab or adalimumab, whereas analysis of T cell populations in intestinal mucosa showed an induction of effector cells. Here, TNF is linked to inflammatory bowel disease.